Skip to content
2000
Volume 6, Issue 3
  • ISSN: 2212-3962
  • E-ISSN: 1574-8901

Abstract

More than 250,000 patients undergo cardiac surgery every year. Although advances in surgical techniques have reduced the peri-operative morbidity and mortality in these patients, atrial fibrillation persists to commonly occur following these surgeries. Traditional therapies have reduced their occurrence; however there are still a significant number of patients who develop this complication. Newer and non-conventional medications are being studied to reduce this cardiac arrhythmia. This review will elaborate on the patho-physiology, and prevention of this arrhythmia. We also aim to summarize recent investigated and patented medications which may result in more effective strategies for prophylaxis against this cardiac arrhythmia.

Loading

Article metrics loading...

/content/journals/prc/10.2174/157489011797377121
2011-09-01
2025-09-03
Loading full text...

Full text loading...

/content/journals/prc/10.2174/157489011797377121
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test